Studies from Mahidol University, Department of Medicine describe new findings in myeloma therapy

Data detailed in 'Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand' have been presented. "Thalidomide based regimen is an effective and well tolerated therapy in multiple myeloma (MM) patients, however, there were a small number of studies written about the results of thalidomide therapy in non-transplant MM patients. We therefore conducted a retrospective study of 42 consecutive patients with newly diagnosed and relapsed/refractory MM treated with thalidomide-based induction regimens followed by thalidomide maintenance therapy," investigators in Thailand...

Want to see the full article?

• Purchase this article for only $3.00